Related references
Note: Only part of the references are listed.Targeting of NMDA receptors in new treatments for schizophrenia
Kenji Hashimoto
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
7,8-Dihydroxyflavone, a TrkB agonist, attenuates behavioral abnormalities and neurotoxicity in mice after administration of methamphetamine
Qian Ren et al.
PSYCHOPHARMACOLOGY (2014)
Abnormalities of the glutamine-glutamate-GABA cycle in the schizophrenia brain
Kenji Hashimoto
SCHIZOPHRENIA RESEARCH (2014)
D-Amino Acid Oxidase Inhibitors as a Novel Class of Drugs for Schizophrenia Therapy
Silvia Sacchi et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders
Kenji Hashimoto et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2013)
Up-Regulation of Neurotrophic Factors by Cinnamon and its Metabolite Sodium Benzoate: Therapeutic Implications for Neurodegenerative Disorders
Arundhati Jana et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Effects of TrkB agonist 7,8-dihydroxyflavone on sensory gating deficits in mice after administration of methamphetamine
Qian Ren et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Inflammation and Schizophrenia
Brian Kirkpatrick et al.
SCHIZOPHRENIA BULLETIN (2013)
A pilot double-blind comparison of D-serine and high-dose olanzapine in treatment-resistant patients with schizophrenia
Marina Ermilov et al.
SCHIZOPHRENIA RESEARCH (2013)
Add-on Treatment of Benzoate for Schizophrenia A Randomized, Double-blind, Placebo-Controlled Trial of D-Amino Acid Oxidase Inhibitor
Hsien-Yuan Lane et al.
JAMA PSYCHIATRY (2013)
A Multicenter, Add-On Randomized Controlled Trial of Low-Dosed-Serine for Negative and Cognitive Symptoms of Schizophrenia
Mark Weiser et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Upregulates Neuroprotective Parkinson Disease Protein DJ-1 in Astrocytes and Neurons
Saurabh Khasnavis et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Contributions of the D-serine pathway to schizophrenia
Viviane Labrie et al.
NEUROPHARMACOLOGY (2012)
Protective effects of the antioxidant sulforaphane on behavioral changes and neurotoxicity in mice after the administration of methamphetamine
Hongxian Chen et al.
PSYCHOPHARMACOLOGY (2012)
Plasma levels of D-serine in Brazilian individuals with schizophrenia
Marilia A. Calcia et al.
SCHIZOPHRENIA RESEARCH (2012)
Effects of the Antioxidant Sulforaphane on Hyperlocomotion and Prepulse Inhibition Deficits in Mice after Phencyclidine Administration
Yumi Shirai et al.
Clinical Psychopharmacology and Neuroscience (2012)
Magnetic Resonance Spectroscopy Study of the Antioxidant Defense System in Schizophrenia
Daisuke Matsuzawa et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View
Jeffrey K. Yao et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Recent Advances in the Discovery of D-Amino Acid Oxidase Inhibitors and Their Therapeutic Utility in Schizophrenia
Dana V. Ferraris et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Levels of D-serine in the brain and peripheral organs of serine racemase (Srr) knock-out mice
Mao Horio et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis
Guochuan E. Tsai et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Comments on 'The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia'
Kenji Hashimoto
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
High dose D-serine in the treatment of schizophrenia
Joshua T. Kantrowitz et al.
SCHIZOPHRENIA RESEARCH (2010)
Co-Administration of a D-Amino Acid Oxidase Inhibitor Potentiates the Efficacy of D-Serine in Attenuating Prepulse Inhibition Deficits After Administration of Dizocilpine
Kenji Hashimoto et al.
BIOLOGICAL PSYCHIATRY (2009)
Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: A possible role of α1-adrenoceptors
Yuko Tanibuchi et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Reduces Microglial and Astroglial Inflammatory Responses
Saurav Brahmachari et al.
JOURNAL OF IMMUNOLOGY (2009)
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha 7 nicotinic receptor agonist SSR180711
Kenji Hashimoto et al.
BIOLOGICAL PSYCHIATRY (2008)
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and D-serine
Kenji Hashimoto et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone:: Role of serotonin 5-HT1A receptors
Hiroko Hagiwara et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Synthesis and biological evaluation of D-amino acid oxidase inhibitors
Dana Ferraris et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline
Yuko Fujita et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Microglial activation in schizophrenia and minocycline treatment
Kenji Hashimoto
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia
Caroline Madeira et al.
SCHIZOPHRENIA RESEARCH (2008)
Evidence implicating the candidate schizophrenia/bipolar disorder susceptibility gene G72 in mitochondrial function
M. Kvajo et al.
MOLECULAR PSYCHIATRY (2008)
Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine
Lin Zhang et al.
NEUROPSYCHOPHARMACOLOGY (2007)
D-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia
Louise Verrall et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: Role of sigma-1 receptors
Kenji Hashimoto et al.
NEUROPSYCHOPHARMACOLOGY (2007)
A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia
Inna Bendikov et al.
SCHIZOPHRENIA RESEARCH (2007)
Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine
Lin Zhang et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of tropisetron:: Role of α7 nicotinic receptors
Kenji Hashimoto et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
G72/G30 in schizophrenia and bipolar disorder: Review and meta-analysis
Sevilla D. Detera-Wadleigh et al.
BIOLOGICAL PSYCHIATRY (2006)
Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol
K Hashimoto et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine - Implications for glutamatergic and dopaminergic model psychoses and cognitive function
JH Krystal et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and D-serine levels
K Yamada et al.
BIOLOGICAL PSYCHIATRY (2005)
Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients
K Hashimoto et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia
U Heresco-Levy et al.
BIOLOGICAL PSYCHIATRY (2005)
Dysfunction of Glia-Neuron Communication in Pathophysiology of Schizophrenia
Kenji Hashimoto et al.
CURRENT PSYCHIATRY REVIEWS (2005)
Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients
Kenji Hashimoto et al.
BMC PSYCHIATRY (2005)
Simultaneous determination of D- and L-serine in rat brain microdialysis sample using a column-switching HPLC with fluorimetric detection
T Fukushima et al.
BIOMEDICAL CHROMATOGRAPHY (2004)
A fully automated amino acid analyzer using NBD-F as a fluorescent derivatization reagent
C Aoyama et al.
BIOMEDICAL CHROMATOGRAPHY (2004)
Decreased serum levels of D-serine in patients with schizophrenia - Evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia
K Hashimoto et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia
I Chumakov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Attenuation of the neuropsychiatric effects of ketamine with lamotrigine -: Support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists
A Anand et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Share Paper
